Artificial intelligence (AI) chatbots have not been approved as medical devices by the U.S. Food and Drug Administration or Health Canada. However, users may overestimate the therapeutic benefits and underestimate the limitations of using such technologies, further deteriorating their mental health. This phenomenon can be classified as a therapeutic misconception where users may infer the chatbot’s purpose is to provide them with real therapeutic care.